Expression of granzyme B and perforin in multiple myeloma

Citation
I. Xagoraris et al., Expression of granzyme B and perforin in multiple myeloma, ACT HAEMAT, 105(3), 2001, pp. 125-129
Citations number
19
Categorie Soggetti
Hematology,"Cardiovascular & Hematology Research
Journal title
ACTA HAEMATOLOGICA
ISSN journal
00015792 → ACNP
Volume
105
Issue
3
Year of publication
2001
Pages
125 - 129
Database
ISI
SICI code
0001-5792(2001)105:3<125:EOGBAP>2.0.ZU;2-#
Abstract
Multiple myeloma (MM) remains an incurable disease by conventional therapy. MM tumor cells evade the immune system and can induce immunosuppression by producing immunomodifying agents such as TGF-beta, FasL, vascular endothel ial growth factor and Muc-1. In the present study, we show that bone marrow cells from a patient suffering from MM IgG/k type, stage IIIA, when cultur ed, expressed granzyme B and perforin, normally expressed exclusively by cy totoxic T cells (CTLs) and natural killer (NK) cells. In addition, phenotyp ic analysis revealed that the cultured cells were activated antigen-present ing cells with NK targeting capacity. We propose that expression of these c ytolytic enzymes may constitute an additional adoptive mechanism by the tum or cells to actively destroy the host immune effector cells. Copyright (C) 2001 S. Karger AG, Basel.